04th week of 2022 patent applcation highlights part 26 |
Patent application number | Title | Published |
20220024866 | Method for Preparation of N-Acetyl Cysteine Amide and Derivatives Thereof | 2022-01-27 |
20220024867 | PROCESS FOR THE PREPARATION OF PERHALOACYL PEROXIDES | 2022-01-27 |
20220024868 | NOVEL LAUROLACTAM PREPARATION METHOD AND SYNTHESIS APPARATUS | 2022-01-27 |
20220024869 | GRP94 SELECTIVE INHIBITORS AND USES THEREOF | 2022-01-27 |
20220024870 | Synthesis of (S)-6-Hydroxytryptophan and Derivatives Thereof | 2022-01-27 |
20220024871 | METHODS FOR PREPARING N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(4-(2-METHYLPROPYLOXY)PH- ENYLMETHYL)CARBAMIDE AND ITS TARTRATE SALT AND POLYMORPHIC FORM C | 2022-01-27 |
20220024872 | ISOLATION AND CHARACTERIZATION OF ANTICANCER COMPOUND FROM SESUVIUM PORTULACASTRUM (L.) L. | 2022-01-27 |
20220024873 | PREPARATION OF SULFONAMIDE HERBICIDE PROCESS INTERMEDIATES | 2022-01-27 |
20220024874 | MULTI-COMPONENT CRYSTALS OF AN ORALLY AVAILABLE HIF PROLYL HYDROXYLASE INHIBITOR | 2022-01-27 |
20220024875 | PROCESS FOR THE MANUFACTURING OF (6AR,10AR)-7-PROPYL-6,6A,7,8,9,10,10A,11-OCTAHYDRO-[1,3]DIOXOLO[4',5':5,6- ]BENZO[1,2-G]QUINOLINE AND (4AR,10AR)-1-PROPYL-1,2,3,4,4A,5,10,10A-OCTAHYDRO-BENZO[G]QUINOLINE-6,7-D- IOL | 2022-01-27 |
20220024876 | SMALL MOLECULE INHIBITION OF SULFOTRANSFERASE SULT1A3 | 2022-01-27 |
20220024877 | COMPOUNDS WITH COPPER- OR ZINC-ACTIVATED TOXICITY AGAINST MICROBIAL INFECTION | 2022-01-27 |
20220024878 | IRE1 SMALL MOLECULE INHIBITORS | 2022-01-27 |
20220024879 | COMPOUNDS FOR TREATMENT OF HEPACI VIRUS INFECTION AND METHOD FOR DETERMINING THERAPY OF HEPACI VIRUS INFECTION, IN PARTICULAR, HCV INFECTION | 2022-01-27 |
20220024880 | PROCESS ROUTE OF COMPOUND OF FORMULA (IV), CRYSTAL FORM AND PREPARATION METHOD THEREFOR | 2022-01-27 |
20220024881 | Small Molecule Prolactin Receptor Inhibitors, Pharmaceutical Compositions and Treatment Methods Using Such Inhibitors | 2022-01-27 |
20220024882 | NOVEL TUMOR ANTIGEN BINDING AGENTS AND USES THEREOF | 2022-01-27 |
20220024883 | METHOD FOR PRODUCING KAKEROMYCIN AND DERIVATIVES THEREOF | 2022-01-27 |
20220024884 | COMPOUNDS AND METHODS FOR INHIBITING VIRAL REPLICATION AND METHODS OF TREATING AND PREVENTING FLAVIVIRAL INFECTIONS | 2022-01-27 |
20220024885 | METHODS FOR PRODUCING VILOXAZINE SALTS AND NOVEL POLYMORPHS THEREOF | 2022-01-27 |
20220024886 | COMPOUND HAVING OXADIAZOLE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | 2022-01-27 |
20220024887 | UBIQUITIN-SPECIFIC PEPTIDASE 24 INHIBITOR, MEDICINAL COMPOSITION INCLUDING THE SAME AND METHOD OF DELAYING OR REVERSING MULTIDRUG RESISTANCE IN CANCERS USING THE SAME | 2022-01-27 |
20220024888 | CRYSTALLINE PPAR-DELTA AGONIST | 2022-01-27 |
20220024889 | CRYSTALLINE FORMS OF A COMPOUND FOR TREATING OR PREVENTING GOUT OR HYPERURICEMIA | 2022-01-27 |
20220024890 | METHODS FOR PREPARING SUBSTITUTED CHROMANONE DERIVATIVES | 2022-01-27 |
20220024891 | THERAPEUTICS TARGETING MUTANT ADENOMATOUS POLYPOSIS COLI (APC) FOR THE TREATMENT OF CANCER | 2022-01-27 |
20220024892 | PROCESS FOR PREPARATION OF ANTHRANILAMIDES | 2022-01-27 |
20220024893 | CRYSTALLINE FORMS OF 1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-METHYLPIPERIDIN-4-YL)-3-(4-CYAN- OPHENYL)UREA MALEATE | 2022-01-27 |
20220024894 | CRYSTALLINE FORMS OF 1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-METHYLPIPERIDIN-4-YL)-3-(4-CYAN- OPHENYL)UREA MALEATE | 2022-01-27 |
20220024895 | METHODS AND COMPOSITIONS FOR SCREENING AND IDENTIFICATION OF SPLICING MODULATORS | 2022-01-27 |
20220024896 | TAU PET IMAGING LIGANDS | 2022-01-27 |
20220024897 | 2-(2,4,5-SUBSTITUTED PHENYLAMINO) PYRIMIDINE DERIVATIVE AND CRYSTALLINE FORM B THEREOF | 2022-01-27 |
20220024898 | CRYSTALLINE FORMS OF 1-(1,2-DIMETHYLPROPYL)-N-ETHYL-5-METHYL-N-PYRIDAZIN-4-YL-PYRAZOLE-4-CARBO- XAMIDE | 2022-01-27 |
20220024899 | BI-FUNCTIONAL NANOHYBRIDS | 2022-01-27 |
20220024900 | Compounds and Their Use for Reducing Uric Acid Levels | 2022-01-27 |
20220024901 | GLP-1R AGONISTS AND USES THEREOF | 2022-01-27 |
20220024902 | Crystalline Forms of 1-[(3R,4S)-4-Cyanotetrahydropyran-3-YL]-3-[(2-Fluoro-6-Methoxy-4-Pyridyl)- Amino]Pyrazole-4-Carboxamide | 2022-01-27 |
20220024903 | POLYMOROPHS OF 5-AZA-4'-THIO-2'-DEOXYCYTIDINE | 2022-01-27 |
20220024904 | REAGENT FOR BIOCONJUGATION VIA IRREVERSIBLE REBRIDGING OF DISULFIDE LINKAGES | 2022-01-27 |
20220024905 | CRYSTALLINE FORM OF PROPANAMIDE DERIVATIVE AND PREPARATION METHOD THEREFOR | 2022-01-27 |
20220024906 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | 2022-01-27 |
20220024907 | COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY | 2022-01-27 |
20220024908 | PREPARATION METHOD FOR DEUTERATED MACROCYCLIC COMPOUND | 2022-01-27 |
20220024909 | NOVEL PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF SOLUBLE GUANYLATE CYCLASE STIMULATORS | 2022-01-27 |
20220024910 | Process for Making Biologically Active Compounds and Intermediates Thereof | 2022-01-27 |
20220024911 | COMPOUND HAVING NOVEL STRUCTURE, COMPLEX COMPRISING SAME, ANTI-CANCER PHARMACEUTICAL COMPOSITION, AND ANTI-CANCER DRUG | 2022-01-27 |
20220024912 | COMPOUNDS FOR TREATMENT OF CANCER | 2022-01-27 |
20220024913 | FGFR4 INHIBITOR AND PREPARATION METHOD AND USE THEREOF | 2022-01-27 |
20220024914 | PROCESS FOR PREPARING N-(5-(3-(7-(3-FLUOROPHENYL)-3H-IMIDAZO[4,5-C]PYRIDIN-2-YL)-1H-INDAZOL-5-Y- L)PYRIDIN-3-YL)-3-METHYLBUTANAMIDE | 2022-01-27 |
20220024915 | INHIBITORS OF VAP-1 | 2022-01-27 |
20220024916 | HETEROCYCLIC COMIPOUND AS CDK-HDAC DUAL PATHWAY INHIBITOR | 2022-01-27 |
20220024917 | PYRIDAZINONES AND METHODS OF USE THEREOF | 2022-01-27 |
20220024918 | TRIAZOLOPYRIDIN-3-ONES OR THEIR SALTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | 2022-01-27 |
20220024919 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | 2022-01-27 |
20220024920 | ADO-RESISTANT CYSTEAMINE ANALOGS AND USES THEREOF | 2022-01-27 |
20220024921 | 1,3,4-OXADIAZOLONE COMPOUND AND PHARMACEUTICAL | 2022-01-27 |
20220024922 | PYRROLO - DIPYRIDINE COMPOUNDS | 2022-01-27 |
20220024923 | MITRAGYNINE ANALOGS AND USES THEREOF | 2022-01-27 |
20220024924 | SOLID STATE FORMS OF LUMATEPERONE SALTS AND PROCESSES FOR PREPARATION OF LUMATEPERONE AND SALTS THEREOF | 2022-01-27 |
20220024925 | Deuterium-Substituted 7-Substituted-2-(Benzylamino)-6-Ozopurine Compounds and Uses Thereof | 2022-01-27 |
20220024926 | A1 ADENOSINE RECEPTOR AGONISTS AND METHODS OF USE THEREOF | 2022-01-27 |
20220024927 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | 2022-01-27 |
20220024928 | 3-(PHENYLSULFONYL)-[1,2,3]TRIAZOLO[1,5A]QUINAZOLIN-5(4H)-ONE DERIVATIVES | 2022-01-27 |
20220024929 | INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) | 2022-01-27 |
20220024930 | ION CHANNEL MODULATORS | 2022-01-27 |
20220024931 | SELECTIVE PI3Kdelta INHIBITOR AND USE THEREOF | 2022-01-27 |
20220024932 | COMPOUNDS HAVING PDE9A INHIBITORY ACTIVITY, AND PHARMACEUTICAL USES THEREOF | 2022-01-27 |
20220024933 | 7 (METHYLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE DERIVATIVES | 2022-01-27 |
20220024934 | SALTS AND PROCESSES OF PREPARING A PI3K INHIBITOR | 2022-01-27 |
20220024935 | Triazolopyridines And Triazolopyrimidines That Lower Stress-Induced P-Tau | 2022-01-27 |
20220024936 | INHIBITORS OF MENIN-MLL INTERACTION | 2022-01-27 |
20220024937 | 3,3-DIFLUOROPIPERIDINE CARBAMATE HETEROCYCLIC COMPOUNDS AS NR2B NMDA RECEPTOR ANTAGONISTS | 2022-01-27 |
20220024938 | Compounds, Compositions and Methods | 2022-01-27 |
20220024939 | SUBSTITUTED 1,2-DIHYDRO-3H-PYRAZOLO[3,4-D]PYRIMIDIN-3-ONES | 2022-01-27 |
20220024940 | STABLE SALT OF 5,10-METHYLENE-(6R)-TETRAHYDROFOLIC ACID | 2022-01-27 |
20220024941 | Preparation Method for Amide Compounds and Use Thereof in Medical Field | 2022-01-27 |
20220024942 | Thermally Sensitive Protecting Groups for Cysteine, and Manufacture and Use Thereof | 2022-01-27 |
20220024943 | HIGH PURITY CANTHARIDIN MANUFACTURING PROCESS AND COMPOSITIONS | 2022-01-27 |
20220024944 | COMPOUNDS TARGETING MUTANT CALRETICULIN | 2022-01-27 |
20220024945 | THERAPEUTIC COMPOUNDS AND COMPOSITIONS, AND METHODS OF USE THEREOF | 2022-01-27 |
20220024946 | BINDING COMPETITORS FOR USE IN MACROPHILIN-BINDING PHARMACEUTICAL ASSAYS AND METHODS OF USE THEREOF | 2022-01-27 |
20220024947 | Purification of Rapamycin Derivatives Using Temperature Induced Phase Separation | 2022-01-27 |
20220024948 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 2022-01-27 |
20220024949 | CU-AND NI-CATALYZED DECARBOXYLATIVE BORYLATION REACTIONS | 2022-01-27 |
20220024950 | METHOD FOR PREPARING BORIC ACID ESTER BASED ON LITHIUM COMPOUND | 2022-01-27 |
20220024951 | Transition Metal Compound and Catalyst Composition Comprising Same | 2022-01-27 |
20220024952 | FLAME RETARDANT COMPOUND, METHOD OF MAKING THE SAME, RESIN COMPOSITION AND ARTICLE MADE THEREFROM | 2022-01-27 |
20220024953 | RAW MATERIAL FOR FORMING THIN FILM BY ATOMIC LAYER DEPOSITION METHOD, METHOD OF PRODUCING THIN FILM, AND ALKOXIDE COMPOUND | 2022-01-27 |
20220024954 | SEQUESTERING COMPOSITIONS AND MATERIALS | 2022-01-27 |
20220024955 | L-GLUFOSINATE INTERMEDIATE AND L-GLUFOSINATE PREPARATION METHOD | 2022-01-27 |
20220024956 | PSILOCIN DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS | 2022-01-27 |
20220024957 | ANTICANCER ACTIVITIES OF A NOVEL FAMILY OF ETHACRYNIC ACID DERIVATIVES | 2022-01-27 |
20220024958 | LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING SAME | 2022-01-27 |
20220024959 | LIGNIN-BASED POLYOLS | 2022-01-27 |
20220024960 | IMPROVED SYNTHESIS OF AN EXPOXIDATION-CATALYST | 2022-01-27 |
20220024961 | METHODS AND COMPOUNDS FOR MODULATING THE SECRETION OR EXPRESSION OF ADHESION PROTEINS OR ANGIOPOIETINS OF CELLS | 2022-01-27 |
20220024962 | SOLID FORMS OF (2S,3S,4S,5R,6S)-3,4,5-TRIHYDROXY-6-(((4AR,10AR)-7-HYDROXY-1-PROPYL-1,2,3- ,4,4A,5,10,10A-OCTAHYDROBENZO[G]QUINOLIN-6-YL)OXY)TETRAHYDRO-2H-PYRAN-2-CA- RBOXYLIC ACID | 2022-01-27 |
20220024963 | SALT OF TRIPHOSPHATE PHOSPHORAMIDATES OF NUCLEOTIDES AS ANTICANCER COMPOUNDS | 2022-01-27 |
20220024964 | Cyclic Di-Nucleotide Compounds as STING Agonists | 2022-01-27 |
20220024965 | DRUG COMPOUND AND PURIFICATION METHODS THEREOF | 2022-01-27 |